A

Acura Pharmaceuticals Inc
OTC:ACUR

Watchlist Manager
Acura Pharmaceuticals Inc
OTC:ACUR
Watchlist
Price: 0.0005 USD Market Closed
Market Cap: 13.3k USD

Wall Street
Price Targets

ACUR Price Targets Summary
Acura Pharmaceuticals Inc

There are no price targets for ACUR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Acura Pharmaceuticals Inc Competitors:
Price Targets
600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
6% Upside
ABBOTINDIA
Abbott India Ltd
27% Upside
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
15% Upside
INVA
Innoviva Inc
67% Upside
000513
Livzon Pharmaceutical Group Inc
28% Upside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
37% Upside
OMER
Omeros Corp
119% Upside

Revenue
Forecast

Revenue Estimate
Acura Pharmaceuticals Inc

For the last 10 years the compound annual growth rate for Acura Pharmaceuticals Inc's revenue is -23%. The projected CAGR for the next 5 years is -9%.

-23%
Past Growth
-9%
Estimated Growth
Estimates Accuracy
96%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Acura Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Acura Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-66%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACUR's stock price target?
Not Available

ACUR doesn't have any price targets made by Wall Street professionals.

What is Acura Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-9%

For the last 10 years the compound annual growth rate for Acura Pharmaceuticals Inc's revenue is -23%. The projected CAGR for the next 5 years is -9%.

Back to Top